Search
for
Sort by
Research 691–720 of 1000+
- Female-patterned alopecia in teenage brothers with unusual histologic features
- Real-World Evidence for Baricitinib in the Treatment of Atopic Dermatitis and Alopecia Areata: Systematic Literature Review 2020–2023
- Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical Trial
- Impact of Previous Alopecia Areata Treatment on Efficacy Responses up to Week 48 Following Ritlecitinib Treatment: A Post Hoc Analysis
- Korean Consensus Criteria for the Severity Classification of Alopecia Areata
- Dermoscopic evaluation of therapeutic response to intralesional triamcinolone acetonide in the treatment of Alopecia areata
- Alopecia Associated With Zidovudine Therapy
- Real-World Experience of Tofacitinib and Baricitinib Use in Alopecia Areata in Greek Population: A Retrospective Analysis With Focus on Safety
- A Bibliometric Analysis of Alopecia Areata Literature over the Past 50 Years.
- Development of Uniform Protocol for Alopecia Areata Clinical Trials
- Etiopathogenesis of Alopecia Areata
- Healthy individuals genetically at-risk for the development of Pemphigus vulgaris or Alopecia areata share disease-like cytokine dysregulation
- Psychometric Properties of the EQ-5D-5L in Patients with Alopecia Areata
- The demographic and clinical profile of patients with alopecia areata in Syria: A study letter
- Clinical Manifestation of Alopecia Areata After COVID-19 Infection or Vaccination
- The Ratio of Typical Clubbing in Pulled-Out Hairs as a Useful Marker in Predicting the Course of Alopecia Areata
- Retrospective Analysis of Systemic Corticosteroids for Alopecia Areata in Pediatric Patients
- Alopecia areata and acitretin
- Alopecia areata and vitamin D: Is there any association?
- Cosmetic Procedures in the Treatment of Alopecia
- COMPARISON OF EFFICACY OF VARIOUS TOPICAL TREATMENT MODALITIES IN ALOPECIA AREATA
- Efficacy, safety and dose response of STS01, a topical controlled release nanoparticle formulation (dithranol/Prosilic), in adults with mild to moderate patchy alopecia areata: A randomised, double-blind, multicentre, phase 2 trial
- Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies
- Clinical and anamnestic features of alopecia areata in ukrainian men
- Medicaid coverage of Janus kinase inhibitors for alopecia areata treatment
- Dermoscopic Assessment of Nail Alterations in Egyptian Patients with Alopecia Areata
- Epidemiology and burden of alopecia areata in Taiwan: a systematic review
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- Life Events Preceding Alopecia Areata Onset—a Descriptive Retrospective Cohort Study Focusing on Strain
- PERSONAL EXPERIENCE OF MONOCHROMATIC EXCIMER PHOTOTHERAPY OF ALOPECIA AREATA